<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="92594">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02145754</url>
  </required_header>
  <id_info>
    <org_study_id>MKP,BSK-0613</org_study_id>
    <nct_id>NCT02145754</nct_id>
  </id_info>
  <brief_title>Culture Media for Borrelia Burgdorferi Sensu Lato</brief_title>
  <official_title>Comparison of Two Culture Media for Cultivation of Borrelia Burgdorferi Sensu Lato</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Centre Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Ljubljana School of Medicine,  Slovenia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Medical Centre Ljubljana</source>
  <oversight_info>
    <authority>Slovenia: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to compare effectiveness of two different culture media
      for cultivation of Borrelia burgdorferi sensu lato from skin specimens obtained from
      patients with erythema migrans.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>detection of Borrelia burgdorferi sensu lato by microscopy in dark field (positive vs. negative)</measure>
    <time_frame>weekly examination during 9 weeks of cultivating for individual specimen</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Erythema Migrans</condition>
  <arm_group>
    <arm_group_label>MKP media</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cultivation of Borrelia burgdorferi sensu lato (from skin specimens obtained from erythema migrans patients) in MKP media</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BSK-H</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cultivation of Borrelia burgdorferi sensu lato (from skin specimens obtained from erythema migrans patients) in BSK-H media</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MKP media</intervention_name>
    <arm_group_label>MKP media</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>BSK-H media</intervention_name>
    <arm_group_label>BSK-H</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  erythema migrans in patients &gt; 18 years

        Exclusion Criteria:

          -  pregnancy or lactation

          -  taking antibiotic with antiborrelial activity within 10 days

          -  erythema migrans localized on face or neck
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Franc Strle, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>UMC Ljubljana</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eva Ruzic-Sabljic, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Ljubljana School of Medicine,  Slovenia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dasa Stupica, MD, PhD</last_name>
    <phone>+386 1 522 2110</phone>
    <email>cerar.dasa@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Franc Strle, MD, PhD</last_name>
    <phone>+386 1 522 2610</phone>
    <email>franc.strle@kclj.si</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UMC Ljubljana, Department of Infectious Diseases</name>
      <address>
        <city>Ljubljana</city>
        <zip>1525</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dasa Stupica, MD,PhD</last_name>
      <phone>+386 1 522 2110</phone>
      <email>cerar.dasa@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Franc Strle, MD,PhD</last_name>
      <phone>+386 1 522 2610</phone>
      <email>franc.strle@kclj.si</email>
    </contact_backup>
    <investigator>
      <last_name>Dasa Stupica, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 20, 2014</lastchanged_date>
  <firstreceived_date>June 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Centre Ljubljana</investigator_affiliation>
    <investigator_full_name>Franc Strle</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>erythema migrans</keyword>
  <keyword>Lyme borreliosis</keyword>
  <keyword>Borrelia burgdorferi</keyword>
  <keyword>skin culture</keyword>
  <keyword>culture media</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lyme Disease</mesh_term>
    <mesh_term>Erythema Chronicum Migrans</mesh_term>
    <mesh_term>Glossitis, Benign Migratory</mesh_term>
    <mesh_term>Erythema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
